Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Topical IKKα inhibitors may help prevent CCS tumours.

Inhibiting certain brain neurons may reduce pain and anxiety in trigeminal neuralgia.

ExoFlo is safe and effective for treating Complex Regional Pain Syndrome symptoms.

A new drug strategy improves hair loss treatment with better results and safety.

The rs1128977 gene variant may affect cholesterol and body measurements.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

We need safe, affordable drugs to fight coronaviruses effectively.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Some drugs may help treat both COVID-19 and radiation injury.